55 related articles for article (PubMed ID: 12162717)
21. Silodosin: a selective alpha1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia.
Schilit S; Benzeroual KE
Clin Ther; 2009 Nov; 31(11):2489-502. PubMed ID: 20109995
[TBL] [Abstract][Full Text] [Related]
22. Role of alpha1-adrenergic receptors in detrusor overactivity induced by cold stress in conscious rats.
Chen Z; Ishizuka O; Imamura T; Aizawa N; Igawa Y; Nishizawa O; Andersson KE
Neurourol Urodyn; 2009; 28(3):251-6. PubMed ID: 18837433
[TBL] [Abstract][Full Text] [Related]
23. Effect of KMD-3213, an alpha1A-adrenoceptor antagonist, on the prostatic urethral pressure and blood pressure in male decerebrate dogs.
Akiyama K; Noto H; Nishizawa O; Sugaya K; Yamagishi R; Kitazawa M; Tsuchida S
Int J Urol; 2001 Apr; 8(4):177-83. PubMed ID: 11260350
[TBL] [Abstract][Full Text] [Related]
24. Alpha1-adrenoceptor antagonists improve bladder storage function through reduction of afferent activity in rats with bladder outlet obstruction.
Yazaki J; Aikawa K; Shishido K; Yanagida T; Nomiya M; Ishibashi K; Haga N; Yamaguchi O
Neurourol Urodyn; 2011 Mar; 30(3):461-7. PubMed ID: 20886573
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I.
Leonardi A; Hieble JP; Guarneri L; Naselsky DP; Poggesi E; Sironi G; Sulpizio AC; Testa R
J Pharmacol Exp Ther; 1997 Jun; 281(3):1272-83. PubMed ID: 9190863
[TBL] [Abstract][Full Text] [Related]
26. [The role of alpha1-adrenoceptor subtypes in benign prostatic hyperplasia-from bed to bench].
Kojima Y; Hayase M; Imura M; Okada S; Kubota Y; Sasaki S; Hayashi Y; Kohri K
Hinyokika Kiyo; 2008 Jun; 54(6):457-62. PubMed ID: 18634446
[TBL] [Abstract][Full Text] [Related]
27. Advantages for transdermal over oral oxybutynin to treat overactive bladder: Muscarinic receptor binding, plasma drug concentration, and salivary secretion.
Oki T; Toma-Okura A; Yamada S
J Pharmacol Exp Ther; 2006 Mar; 316(3):1137-45. PubMed ID: 16282521
[TBL] [Abstract][Full Text] [Related]
28. RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification.
Ford AP; Arredondo NF; Blue DR; Bonhaus DW; Jasper J; Kava MS; Lesnick J; Pfister JR; Shieh IA; Vimont RL; Williams TJ; McNeal JE; Stamey TA; Clarke DE
Mol Pharmacol; 1996 Feb; 49(2):209-15. PubMed ID: 8632751
[TBL] [Abstract][Full Text] [Related]
29. Effects of α1-adrenoceptor antagonists on phenylephrine-induced salivary secretion and intraurethral pressure elevation in anesthetized rats.
Yanai-Inamura H; Ohtake A; Noguchi Y; Hatanaka T; Suzuki M; Ueshima K; Sato S; Sasamata M
Eur J Pharmacol; 2012 Mar; 679(1-3):127-31. PubMed ID: 22314219
[TBL] [Abstract][Full Text] [Related]
30. Alpha1L-adrenoceptors mediate contractions of the isolated mouse prostate.
Gray KT; Ventura S
Eur J Pharmacol; 2006 Jul; 540(1-3):155-61. PubMed ID: 16716294
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biodistribution of [11C]R107474, a new radiolabeled alpha2-adrenoceptor antagonist.
Van der Mey M; Windhorst AD; Klok RP; Herscheid JD; Kennis LE; Bischoff F; Bakker M; Langlois X; Heylen L; Jurzak M; Leysen JE
Bioorg Med Chem; 2006 Jul; 14(13):4526-34. PubMed ID: 16517171
[TBL] [Abstract][Full Text] [Related]
32. Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action.
Benning CM; Kyprianou N
Cancer Res; 2002 Jan; 62(2):597-602. PubMed ID: 11809715
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of histological structure and its effect on the distribution of alpha1-adrenoceptors in human benign prostatic hyperplasia.
Kurimoto S; Moriyama N; Hamada K; Kawabe K
Br J Urol; 1998 Mar; 81(3):388-93. PubMed ID: 9523657
[TBL] [Abstract][Full Text] [Related]
34. Muscarinic Receptor Binding and Plasma Drug Concentration after the Oral Administration of Propiverine in Mice.
Ito Y; Kato A; Fujino Oki T; Okura T; Yoshida K; Nanri M; Yamada S
Low Urin Tract Symptoms; 2010 Apr; 2(1):43-9. PubMed ID: 26676219
[TBL] [Abstract][Full Text] [Related]
35. Graphical Ranking of Divisors to Get the Most out of a Resolution-Enhanced Kendrick Mass Defect Plot.
Nakamura S; Cody RB; Sato H; Fouquet T
Anal Chem; 2019 Feb; 91(3):2004-2012. PubMed ID: 30582791
[TBL] [Abstract][Full Text] [Related]
36. Association of silodosin, tamsulosin, and naftopidil with delirium: analysis of the pharmacovigilance database in Japan.
Kotake K; Noritake Y; Kawakami Y
Int J Clin Pharm; 2023 Oct; 45(5):1252-1259. PubMed ID: 37713027
[TBL] [Abstract][Full Text] [Related]
37. Cognitive Function and Urologic Medications for Lower Urinary Tract Symptoms.
Kim YJ; Tae BS; Bae JH
Int Neurourol J; 2020 Sep; 24(3):231-240. PubMed ID: 33017894
[TBL] [Abstract][Full Text] [Related]
38. α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.
Yamada S; Ito Y; Tsukada H
Br J Clin Pharmacol; 2011 Aug; 72(2):205-17. PubMed ID: 21265873
[TBL] [Abstract][Full Text] [Related]
39. Selective and sustained occupancy of prostatic alpha1-adrenoceptors by oral administration of KMD-3213 and its plasma concentration in rats.
Okura T; Yamada S; Abe Y; Kimura R
J Pharm Pharmacol; 2002 Jul; 54(7):975-82. PubMed ID: 12162717
[TBL] [Abstract][Full Text] [Related]
40. Ex vivo occupancy by tamsulosin of alpha1-adrenoceptors in rat tissues in relation to the plasma concentration.
Ohkura T; Yamada S; Deguchi Y; Kimura R; Matsushima H; Higuchi S; Inagaki O; Honda K; Takenaka T
Life Sci; 1998; 63(24):2147-55. PubMed ID: 9851306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
